CRP and malignant colon neoplasm: In a study with 525 patients with colon cancer with a median follow-up time of 4.5 years, Kersten et al. found that a preoperative CRP of >30 mg/L was associated with inferior disease specific survival (HR 2.1 95% CI (1.39–3.10)).